References
- Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75:279–286.
- Löscher W, Klein P. The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS Drugs. 2021;35:935–963.
- Ben-Menachem E, Biton V, Jatuzis D, et al. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia. 2007;48:1308–1317.
- Husain A, Chung S, Faught E, et al. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial. Epilepsia. 2012;53:521–528.
- Brickel N, Hewett K, Rayner K, et al. Safety of retigabine in adults with partial-onset seizures after long-term exposure: focus on unexpected ophthalmological and dermatological events. Epilepsy Behav. 2020;102:106580.
- Anticonvulsant Potiga Discontinued in June 2017 [Internet]. Neurology live. [cited 2022 May 16]. Available from: https://www.neurologylive.com/view/anticonvulsant-potiga-discontinued-june-2017.
- Devinsky O, Spruill T, Thurman D, et al. Recognizing and preventing epilepsy-related mortality: a call for action. Neurology. 2016;86:779–786.
- Nashef L, So EL, Ryvlin P, et al. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia. 2012;53:227–233.
- Simon K, Sheckley H, Anderson CL, et al. A review of fenfluramine for the treatment of Dravet syndrome patients. Curr Res Pharmacol Drug Discov. 2022;3:100078.
- Sullivan J, Specchio N, Devinsky O, et al. Fenfluramine significantly reduces day-to-day seizure burden by increasing number of seizure-free days and time between seizures in patients with Dravet syndrome: a time-to-event analysis. Epilepsia. 2022;63:130–138.
- French JA, Perucca E, Sander JW, et al. FDA safety warning on the cardiac effects of lamotrigine: an advisory from the Ad Hoc ILAE/AES Task Force. Epilepsia Open. 2021;6:45–48.
- Harmer AR, Valentin J-P, Pollard CE. On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex. Br J Pharmacol. 2011;164:260–273.